ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 215721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 215721; 2) Community: the network communities that were significantly associated with the response to NSC 215721; 3) Molecule: the relationships between components within communities and NSC 215721; 4) MDR: the compounds that were significantly associated with the NSC 215721.

NSC Compound Enrichment Correlation
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0186186224062458 0.30031408
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0186186224062458 0.048649725
NSC 9594 Safranin bluish 0.0186186224062458 0.29019044
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0186186224062459 0.2618939
NSC 132230 Null 0.0186186224062459 0.11418892
NSC 151982 Null 0.0186186224062459 0.49414935
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0186186224062459 0.25796524
NSC 10037 Null 0.0220039422291538 -0.056304908
NSC 121713 Null 0.0220039422291538 0.32589682
NSC 163088 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride (9CI) 0.0220039422291538 0.1002971
Total:76  Current:35    [First] [Prev] [Next] [Last]